The findings also indicate that immunisation protection against severe Covid did not deteriorate during the course of the trial, which lasted up to five months

New Delhi: The government has authorised the export of Russia’s single-dose COVID-19 vaccine Sputnik Light, which is manufactured in India, because the vaccine has not yet been licenced for emergency use in India, according to sources on Sunday.

Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V which is being used in India’s anti-COVID inoculation programme after getting emergency use authorisation from India’s Drug Regulator in April.

The Russian ambassador had urged the Indian government to allow the export of  Sputnik Light produced by Hetero Biopharma, one of the partners of the Russian Direct Investment Fund (RDIF) in the production of the jab, to his country till the vaccine gets emergency use authorisation from India’s drug regulator.

Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V which is being used in India’s anti-COVID inoculation programme after getting emergency use authorisation from India’s Drug Regulator in April.

The Russian ambassador had urged the Indian government to allow the export of  Sputnik Light produced by Hetero Biopharma, one of the partners of the Russian Direct Investment Fund (RDIF) in the production of the jab, to his country till the vaccine gets emergency use authorisation from India’s drug regulator.

In a communication to the Centre, Russian Ambassador Nicholay Kudashev had stated that Hetero Biopharma Limited already has manufactured one million doses of Component 1 of the Sputnik V and two million doses of the Sputnik Light but the six-month shelf life of the vaccine may expire before its registration which will result in the wastage of vaccine doses, sources said.

“The government has permitted Indian drug firm Hetero Biopharma to export 40 lakh doses of Sputnik Light to Russia. The decision was taken this week following detailed deliberations,” a source said.

Over the past months, the RDIF has been working closely with Indian pharmaceutical companies to ramp up the production of Sputnik vaccine in India that could be used in the local and global markets, the ambassador had stated in his communication last month.
At the moment RDIF together with Dr Reddy’s Laboratories is working with authorities concerned on the registration of the Sputnik Light in India.

Medically Speaking

Share
Published by
Medically Speaking

Recent Posts

The Hidden Costs of Excessive Screen Time: How It Impacts Your Child’s Behavior and What You Can Do About It

Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…

6 hours ago

Transform Your Heart Health: Simple Everyday Diet and Lifestyle Changes for a Happier, Stronger Heart

Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…

6 hours ago

“Unraveling the Truth: Do Brain Tumours Only Affect Older Adults? Debunking Myths and Shedding Light on a Complex Condition”

This article explores the common misconception that brain tumours primarily affect older adults, revealing the…

6 hours ago

“Revolutionary Breakthrough: First-Ever Ovarian Cancer Vaccine Set to Transform Women’s Health and Combat a Silent Killer”

The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…

6 hours ago

“Battling the Monsoon Surge: Essential Strategies to Prevent Dengue and Chikungunya Infections in Delhi”

As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…

7 hours ago

NATURAL vs CHEMICAL SKINCARE: THE ESSENTIAL GUIDE TO CHOOSING WHAT’S BEST FOR YOUR SKIN

Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…

7 hours ago